Eli Lilly’s Foundayo weight-loss pill is now available in the U.S. following the Food and Drug Administration’s approval earlier this month. – Mike Blake/Reuters
Eli Lilly’s Foundayo weight-loss pill is now available in the U.S. following the Food and Drug Administration’s approval earlier this month, the company said.
The drug is available through Eli Lilly’s direct sales platform and telehealth providers and is shipping to retail pharmacies, the company said.
Amazon Pharmacy and GoodRx said patients would be able to access Foundayo through their platforms.
Foundayo is Eli Lilly’s attempt to counter Novo Nordisk’s successful launch of a pill version of its Wegovy drug, which it has been selling since the start of this year.
The companies are betting that the launch of GLP-1 pills will increase demand for the drugs, attracting those who are averse to needles or who don’t think their weight is problematic enough to warrant an injection.
The starting dose of Foundayo will cost $149 a month, Eli Lilly said–the same as the starting dose of Novo Nordisk’s GLP-1 pill.
Write to Nicholas G. Miller at nicholas.miller@wsj.com